Alzheimer's Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Alzheimer's Disease stocks.

Alzheimer's Disease Stocks Recent News

Date Stock Title
Mar 29 LLY Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
Mar 28 LLY Starter Stock Portfolio: 12 Safe Stocks To Invest In Now
Mar 28 LLY 2 Top Biotech Buyout Candidates
Mar 28 LLY 10 Best Growth Stocks To Invest In Now
Mar 28 LLY 13 Hot Stocks to Invest in According to Wall Street Analysts
Mar 28 LLY Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
Mar 28 LLY Insiders Are Dumping These 10 Healthcare Stocks
Mar 28 LLY Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
Mar 28 LLY Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Mar 28 LLY Prediction: This Will Be the Next "Magnificent Seven" Stock
Mar 27 LLY Dow Jones Futures Fall On Hawkish Fed; Small Caps Jump As Nvidia, Growth Leaders Skid
Mar 27 LLY US Companies In Japan Wary On Market Intervention As Yen Hits 34-Year Low Vs. Dollar
Mar 27 LLY Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
Mar 27 LLY IBD Stock Of The Day Eli Lilly Jumps Early Entry As Viking Charges Obesity Space
Mar 27 LLY Amazon (AMZN) Expands Same-Day Medication Delivery Service
Mar 26 LLY Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors
Mar 26 LLY Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
Mar 26 LLY Don't 'run away' from tech, but do broaden out: Strategist
Mar 26 LLY Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
Mar 26 IGC IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
Alzheimer's Disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD; however, evidence to support these recommendations is not strong. There are no medications or supplements that have been shown to decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programmes may be beneficial with respect to activities of daily living and can potentially improve outcomes. Behavioural problems or psychosis due to dementia are often treated with antipsychotics, but this is not usually recommended, as there is little benefit with an increased risk of early death.In 2015, there were approximately 29.8 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2015, dementia resulted in about 1.9 million deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.

Browse All Tags